CSIP Participates in FDA Opioid Summit

CSIP Opioid Awareness News

The U.S. Food and Drug Administration (FDA) held an Opioid Summit on June 27, 2018. The purpose of the Summit was to invite “internet stakeholders, government entities, academic researchers, and advocacy groups to discuss ways to collaboratively take stronger action in combating the opioid crisis by reducing the availability of illicit opioids online.” CSIP director, Marjorie Clifton, participated in the Summit. The following articles, published on June 27, 2018 highlight the Summit and CSIP’s involvement.